Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Endo Unit Shutdown Could Strand Incontinence Treatment Praised By FDA Panel

This article was originally published in The Gray Sheet

Executive Summary

Endo International plans to shutter its Astora Women's Health business unit – formerly part of American Medical Systems – this month due to ongoing legal concerns tied to the company’s vaginal mesh products. What’s unclear is what this means for the company’s investigational fecal incontinence treatment, which received unanimous support from an FDA advisory panel just days before the shutdown was announced.

Advertisement

Related Content

AMS: Pelvic Mesh Plaintiffs Enticed
TOPAS Fecal Incontinence Device Gets Unanimous Support For Approval At FDA Panel
PMA Mandate Set For Pelvic Organ Prolapse Transvaginal Mesh
Medtech Solutions For The "Other" Incontinence
Boston Sci Ups Urology Focus With $1.6 Billion AMS Deal
Endo Boosts Urology Device Presence With $2.9 Billion AMS Bid

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT034596

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel